Coccidioidomycosis. Part II.
D000666:Amphotericin B / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000175:diagnosis; D003047:Coccidioidomycosis / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D004802:Eosinophilia / Q000175:diagnosis; D004890:Erythema / Q000175:diagnosis; D004892:Erythema Multiforme / Q000175:diagnosis; D004893:Erythema Nodosum / Q000175:diagnosis; D005006:Ethnicity; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000628:therapy; D008581:Meningitis / Q000175:diagnosis; D008825:Miconazole / Q000627:therapeutic use; D010019:Osteomyelitis / Q000175:diagnosis; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012874:Skin Diseases, Infectious / Q000175:diagnosis; D013717:Tenosynovitis / Q000175:diagnosis; D014165:Transfer Factor / Q000627:therapeutic use; D014481:United States
D014165:Transfer Factor; D008825:Miconazole; D000666:Amphotericin B